 Lots of good answers here. Would say: (1) US exposure / potential acceleration in volume declines due to oral + vape, (2) velo weak in US (3) FX?, (4) potential sale of ITC to cover debt paydown? (5) FDA/US administration idiocy, (6) ex US mkts hit price elasticity wall